Multiple focal nodular hyperplasias induced by oxaliplatin-based chemotherapy

World Journal of Hepatology

Volumn 5, Issue 6, 2013, Pages 340-344

  Donadon, Matteo ^a   Tommaso, Luca Di ^a   Roncalli, Massimo ^a   Torzilli, Guido ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Colorectal cancer; Colorectal liver metastasis; Focal nodular hyperplasia; Oxaliplatin; Systemic chemotherapy

Indexed keywords

EID: 84880672386     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v5.i6.340     Document Type: Article

References (13)

1. Nakanuma Y. Nodular regenerative hyperplasia of the liv-er: retrospective survey in autopsy series. J Clin Gastroenterol 1990; 12: 460-465 [PMID: 1975817]
2. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990; 11: 787-797 [PMID: 2189821 DOI: 10.1002/hep.1840110512]
3. Molina E, Reddy KR. Noncirrhotic portal hypertension. Clin Liver Dis 2001; 5: 769-787 [PMID: 11565140 DOI: 10.1016/S1089-3261(05)70191-4]
4. Dachman AH, Ros PR, Goodman ZD, Olmsted WW, Ishak KG. Nodular regenerative hyperplasia of the liver: clinical and radiologic observations. AJR Am J Roentgenol 1987; 148: 717-722 [PMID: 3548283]
5. Rubbia-Brandt L, Lauwers GY, Wang H, Majno PE, Tanabe K, Zhu AX, Brezault C, Soubrane O, Abdalla EK, Vauthey JN, Mentha G, Terris B. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin- associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 2010; 56: 430-439 [PMID: 20459550 DOI: 10.1111/j.1365-2559.2010.03511.x]
6. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane O, Chaussade S, Mentha G, Terris B. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004; 15: 460-466 [PMID: 14998849 DOI: 10.1093/annonc/mdh095]
7. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, HoffPM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA, Abdalla EK. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006; 24: 2065-2072 [PMID: 16648507 DOI: 10.1200/JCO.2005.05.3074]
8. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 2005; 200: 845-853 [PMID: 15922194 DOI: 10.1016/j.jamcollsurg.2005.01.024]
9. Wicherts DA, de Haas RJ, Sebagh M, Ciacio O, Lévi F, Paule B, Giacchetti S, Guettier C, Azoulay D, Castaing D, Adam R. Regenerative nodular hyperplasia of the liver related to chemotherapy: impact on outcome of liver surgery for colorectal metastases. Ann Surg Oncol 2011; 18: 659-669 [PMID: 20976564]
10. Bioulac-Sage P, Laumonier H, Cubel G, Rossi JZ, Balabaud C. Hepatic resection for inflammatory hepatocellular adenomas: pathological identification of micronodules expressing inflammatory proteins. Liver Int 2010; 30: 149-154 [PMID: 19845852 DOI: 10.1111/j.1478-3231.2009.02098.x]
11. Hubert C, Sempoux C, Horsmans Y, Rahier J, Humblet Y, Machiels JP, Ceratti A, Canon JL, Gigot JF. Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases. Liver Int 2007; 27: 938-943 [PMID: 17696932 DOI: 10.1111/j.1478-3231.2007.01511.x]
12. Ribero D, Wang H, Donadon M, Zorzi D, Thomas MB, Eng C, Chang DZ, Curley SA, Abdalla EK, Ellis LM, Vauthey JN. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatinbased chemotherapy for colorectal liver metastases. Cancer 2007; 110: 2761-2767 [PMID: 17960603]
13. Lubezky N, Metser U, Geva R, Nakache R, Shmueli E, Klausner JM, Even-Sapir E, Figer A, Ben-Haim M. The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings. J Gastrointest Surg 2007; 11: 472-478 [PMID: 17436132]